Dolby Laboratories (DLB) Tops Q3 EPS by 24c

Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.71, $0.24 better than the analyst estimate of $0.47. Revenue for the quarter came in at $286.8 million versus the consensus estimate of $278.79 million.

GUIDANCE:

Dolby Laboratories sees Q4 2021 EPS of $0.47-$0.62, versus the consensus of $0.66. Dolby Laboratories sees Q4 2021 revenue of $280-310 million, versus the consensus of $304.8 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• CAVA Group Inc (CAVA) PT Lowered to $95 at Guggenheim
• Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance